Cheng Peng, Li Gang, Yang Sheng Sheng, Liu Rui, Jin Gang, Zhou Xu Yu, Hu Xian Gui
Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.
Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, People's Republic of China.
FEBS Lett. 2015 Oct 7;589(20 Pt B):3079-84. doi: 10.1016/j.febslet.2015.04.049. Epub 2015 May 8.
Menin, encoded by the MEN1 gene, was initially identified as a tumor suppressor for endocrine neoplasia. Our previous report showed that Menin enhances PPARα transactivity preventing triglyceride accumulation in the liver. Here, we further explore the role of Menin in liver steatosis. Transient transfection assays demonstrate that Menin inhibits the transcriptional activity of nuclear receptor liver X receptor α (LXRα). Accordingly, Menin overexpression results in reduced expression of LXRα target genes, such as lipogenic enzymes including SREBP-1c, FASN and SCD-1. Co-immunoprecipitation assays revealed physical interaction between Menin and LXRα. Collectively, our data suggest that Menin acts as a novel corepressor of LXRα and functions as a negative regulator of hepatic lipogenesis.
由MEN1基因编码的Menin最初被鉴定为内分泌肿瘤的肿瘤抑制因子。我们之前的报告显示,Menin增强PPARα的转录活性,防止肝脏中甘油三酯的积累。在这里,我们进一步探讨Menin在肝脏脂肪变性中的作用。瞬时转染试验表明,Menin抑制核受体肝脏X受体α(LXRα)的转录活性。因此,Menin过表达导致LXRα靶基因的表达降低,如包括SREBP-1c、FASN和SCD-1在内的脂肪生成酶。免疫共沉淀试验揭示了Menin与LXRα之间的物理相互作用。总体而言,我们的数据表明,Menin作为LXRα的新型共抑制因子,发挥肝脏脂肪生成负调节因子的作用。